Semaglutide Injections

We provide comprehensive information about a groundbreaking medication known as semaglutide. This innovative pharmaceutical compound has garnered significant attention in the medical community for its remarkable potential in managing certain health conditions. Semaglutide belongs to a class of medications called GLP-1 receptor agonists, which are specifically designed to enhance the body’s natural production of insulin.

This remarkable compound has demonstrated promising results in the management of various health conditions. It has been extensively studied for its efficacy at controlling blood sugar levels in people with type 2 diabetes, helping them achieve better glycemic control. Semaglutide acts by stimulating insulin secretion, reducing glucagon production, and delaying gastric emptying, resulting in improved blood sugar regulation.

Moreover, semaglutide has also shown promise in weight management. Research indicates that this medication can lead to significant and sustainable weight loss in individuals with obesity, which can positively impact their overall health and well-being. By targeting the brain’s appetite control center, semaglutide helps to reduce food cravings and increase satiety, thereby supporting long-term weight management goals.

Once-Weekly Semaglutide injections in Adults that are Overweight. At Timeless Medical Spa and Weight Loss, we are here to provide you with a FULL weight loss program. The Semaglutide weight loss study was for overweight participants that were given 2.4 mg of Semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight. See study below.

“Todays approval offers adults with obesity or overweight a beneficial new treatment option to incorporate into a weight management program,” said John Sharretts, M.D., deputy director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research. “FDA remains committed to facilitating the development and approval of additional safe and effective therapies for adults with obesity or overweight.”

FAQs

How does Semaglutide work?

Works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake. The medication dose must be increased gradually over 16 to 20 weeks to 2.4 mg once weekly to reduce gastrointestinal side effects.

What to expect based on trial tests?

The largest placebo-controlled trial enrolled adults without diabetes. The average age at the start of the trial was 46 years and 74% of patients were female. The average body weight was 231 pounds (105 kg) and average BMI was 38 kg/m2. Individuals who received Wegovy lost an average of 12.4% of their initial body weight compared to individuals who received placebo. Another trial enrolled adults with type 2 diabetes. The average age was 55 years and 51% were female. The average body weight was 220 pounds (100 kg) and average BMI was 36 kg/m2. In this trial, individuals who received Wegovy lost 6.2% of their initial body weight compared to those who received placebo.